Can iron deficiency coexist with inflammation-driven iron restriction and mask diagnostic markers?

Diagnosing iron status is complex because absolute iron deficiency (depleted stores) and functional iron deficiency (sequestration due to inflammation) frequently overlap, especially in chronic disease states. This coexistence creates a "mixed state" that often masks true iron deficiency when using standard diagnostic markers.

Clinical and diagnostic evidence

The interpretation of iron markers is significantly confounded by the presence of inflammation. Research consistently shows that standard diagnostic thresholds for iron deficiency become insensitive in these scenarios:

• Ferritin as an acute-phase reactant: Serum ferritin levels increase in response to systemic inflammation, independent of actual iron stores. In patients with inflammatory conditions, ferritin levels may appear "normal" or even elevated (e.g., >100 µg/L) despite severely depleted bone marrow iron.
• Need for adjusted cutoffs: Because of this inflammatory rise, clinical guidelines for chronic kidney disease, heart failure, and inflammatory bowel disease recommend higher ferritin cutoffs—often <100 µg/L or even <300 µg/L—to identify deficiency.
• The role of TSAT: Transferrin saturation (TSAT) is frequently used alongside ferritin to resolve ambiguity. A TSAT below 20% often indicates iron-restricted erythropoiesis, even if ferritin remains elevated.

Mechanistic explanations

The primary driver of inflammation-related iron restriction is the peptide hormone hepcidin.

• Hepcidin-ferroportin axis: In response to inflammatory cytokines (primarily IL-6), the liver increases hepcidin production. Hepcidin binds to and degrades ferroportin, the only known cellular iron exporter.
• Iron sequestration: This degradation traps iron within macrophages and enterocytes, preventing it from entering the circulation. The result is hypoferremia (low serum iron) and restricted delivery to the bone marrow, even if total body iron is sufficient.
• Marker interference: While hepcidin causes functional deficiency, the inflammatory environment simultaneously stimulates ferritin synthesis, creating a clinical picture of high storage markers but low circulating iron.

Bottom line

Iron deficiency and inflammation-driven sequestration are not mutually exclusive. Inflammation can falsely elevate ferritin levels, necessitating the use of higher diagnostic cutoffs and additional markers like TSAT or soluble transferrin receptor (sTfR) to accurately assess iron status.